Boosting COVID-19 Survival with Umbilical Cord Stem Cells
A small study using umbilical cord blood stem cells to treat COVID-19 suggests that these stem cells could significantly improve survival rates and accelerate recovery time for critically ill COVID-19 patients. The study recently published in Stem Cells Translational...
COVID-19 and stem cells: clinical trial update
The pandemic has seen the emergence of numerous stem cell therapies to combat the virus and its disruption of human society across the world. In particular, a growing number of clinical trials are using mesenchymal stem cells to treat COVID-19. Here is a quick update...
Muscular Dystrophy Awareness Month
September is Muscular Dystrophy Month and as part the effort to raise awareness of this condition, we will be discussing what muscular dystrophy is, how it affects our bodies, and how cord blood stem cells could help sufferers. What is muscular dystrophy? Muscular...
Stem Cell Therapy: Clinical Trial Reveals Promise for COVID-19 Treatment
Initial data from early clinical trials show that mesenchymal stem cells could potentially stop the virus, calm the immune response and repair tissue damage caused by COVID-19. As the pandemic continues, the race is truly on to find an effective treatment for...
Treating Autism in Children: Clinical Trial Validates Cord Blood Infusion
A new phase II clinical trial has indicated that umbilical cord blood infusions are safe and are associated with improved social and communication abilities in children with autism. Results from the study show that umbilical cord blood infusion were safe and well...
